Cami S. Sima

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

Akihiko Yoshizawa, Noriko Motoi, Gregory J. Riely et al. · Modern Pathology · 2011 · 987 citations

Further Revision, Surgical Oncology, Proposed Iaslc/ats/ers Classification +9

Variation of Breast Cancer Risk Among BRCA1/2 Carriers

Colin B. Begg, Robert W. Haile, Åke Borg et al. · JAMA · 2008 · 281 citations · Full text

Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers

Alexander Drilon, Isabella Bergagnini, Lukas Delasos et al. · Annals of Oncology · 2016 · 116 citations · Full text

A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma

Alan L. Ho, Lara Dunn, Eric J. Sherman et al. · Annals of Oncology · 2016 · 115 citations · Full text

Surgical Oncology, Malignant Disease, Medicine +6

Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine‐refractory thyroid cancer

Eric J. Sherman, Lara Dunn, Alan L. Ho et al. · Cancer · 2017 · 70 citations · Full text